| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $3,117,228 | 6 | 23 |
Sells | $118,389 | 20 | 77 |
| SCHULER JACK W | Emeritus Director | 6 | $3.12M | 0 | $0 | $3.12M |
| Vazquez Chris | Chief Accounting Officer | 0 | $0 | 4 | $4,490 | $-4,490 |
| Pestano Gary Anthony | Chief Development Officer | 0 | $0 | 4 | $15,152 | $-15,152 |
| O'Kane Kieran | Chief Commercial Officer | 0 | $0 | 4 | $15,343 | $-15,343 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | 0 | $0 | 4 | $19,134 | $-19,134 |
| Hutton Scott | President & CEO | 0 | $0 | 4 | $64,270 | $-64,270 |
Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lung Nodule Risk Assessment (which includes Nodify XL2 and Nodify CDT). These assessments enable clinicians to evaluate the risk of lung cancer in patients with suspicious nodules, aiding in the reclassification of malignancy risk and guiding appropriate treatment pathways. Beyond risk assessment, Biodesix offers additional lung cancer diagnostics …
Over the last 12 months, insiders at Biodesix, Inc. have bought $3.12M and sold $118,389 worth of Biodesix, Inc. stock.
On average, over the past 5 years, insiders at Biodesix, Inc. have bought $32.7M and sold $170,551 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SCHULER JACK W (Emeritus Director) — $3.12M.
The last purchase of 15,000 shares for transaction amount of $366,992 was made by SCHULER JACK W (Emeritus Director) on 2026‑08‑12.
| 2026-08-12 | SCHULER JACK W | Emeritus Director | 15,000 0.1861% | $24.47 | $366,992 | +8.44% | ||
| 2026-08-11 | SCHULER JACK W | Emeritus Director | 13,700 0.1662% | $24.01 | $328,911 | +7.69% | ||
| 2026-08-10 | SCHULER JACK W | Emeritus Director | 13,900 0.1317% | $24.25 | $337,029 | +5.03% | ||
| 2026-02-23 | Sale | Hutton Scott | President & CEO | 1,490 0.0187% | $12.78 | $19,036 | +57.95% | |
| 2026-02-23 | Sale | Cowie Robin Harper | CFO, Sec'y & Treasurer | 535 0.0067% | $12.78 | $6,835 | +57.95% | |
| 2026-02-23 | Sale | Pestano Gary Anthony | Chief Development Officer | 556 0.007% | $12.78 | $7,103 | +57.95% | |
| 2026-02-23 | Sale | O'Kane Kieran | Chief Commercial Officer | 535 0.0067% | $12.78 | $6,835 | +57.95% | |
| 2026-02-23 | Sale | Vazquez Chris | Chief Accounting Officer | 211 0.0027% | $12.78 | $2,696 | +57.95% | |
| 2026-02-10 | Sale | Hutton Scott | President & CEO | 3,559 0.0434% | $10.08 | $35,889 | +88.51% | |
| 2026-02-10 | Sale | Cowie Robin Harper | CFO, Sec'y & Treasurer | 941 0.0115% | $10.08 | $9,489 | +88.51% | |
| 2026-02-10 | Sale | Pestano Gary Anthony | Chief Development Officer | 540 0.0066% | $10.08 | $5,445 | +88.51% | |
| 2026-02-10 | Sale | O'Kane Kieran | Chief Commercial Officer | 584 0.0071% | $10.08 | $5,889 | +88.51% | |
| 2026-02-10 | Sale | Vazquez Chris | Chief Accounting Officer | 101 0.0012% | $10.08 | $1,018 | +88.51% | |
| 2026-01-26 | SCHULER JACK W | Emeritus Director | 20,000 0.2941% | $11.80 | $236,064 | +85.53% | ||
| 2026-01-23 | SCHULER JACK W | Emeritus Director | 80,000 1.0114% | $11.81 | $944,672 | +59.24% | ||
| 2026-01-22 | SCHULER JACK W | Emeritus Director | 82,465 1.0232% | $10.96 | $903,561 | +68.20% | ||
| 2026-01-16 | Sale | Hutton Scott | President & CEO | 970 0.0136% | $8.15 | $7,905 | +123.54% | |
| 2026-01-16 | Sale | Cowie Robin Harper | CFO, Sec'y & Treasurer | 298 0.0042% | $8.15 | $2,428 | +123.54% | |
| 2026-01-16 | Sale | Pestano Gary Anthony | Chief Development Officer | 298 0.0042% | $8.15 | $2,428 | +123.54% | |
| 2026-01-16 | Sale | O'Kane Kieran | Chief Commercial Officer | 298 0.0042% | $8.15 | $2,428 | +123.54% |
| SCHULER JACK W | Emeritus Director | 555810 6.8279% | $11.7M | 43 | 0 | <0.0001% |
| Hutton Scott | President & CEO | 48767 0.5991% | $1.03M | 2 | 28 | <0.0001% |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | 16231 0.1994% | $341,662.55 | 2 | 28 | <0.0001% |
| Kennedy Lawrence T. Jr | 10411024 127.8952% | $219.15M | 5 | 0 | <0.0001% | |
| Strobeck Matthew | director | 2606879 32.0244% | $54.87M | 6 | 0 | <0.0001% |
| PATIENCE JOHN | Chairman | 2153298 26.4524% | $45.33M | 10 | 0 | <0.0001% |
| Kayyem Jon Faiz | director | 173913 2.1365% | $3.66M | 2 | 0 | +22.31% |
| MASSARANY HANY | director | 53364 0.6556% | $1.12M | 4 | 0 | <0.0001% |
| Watts Charles M | director | 51333 0.6306% | $1.08M | 4 | 0 | +1.25% |
| Georgantas Robert William III | Chief Scientific Officer | 26114 0.3208% | $549,699.70 | 1 | 6 | +19.87% |
| Increased Positions | 14 | +42.42% | 398,256 | +27.72% |
| Decreased Positions | 13 | -39.39% | 205,538 | -14.31% |
| New Positions | 7 | New | 352,645 | New |
| Sold Out Positions | 8 | Sold Out | 100,915 | Sold Out |
| Total Postitions | 34 | +3.03% | 2M | +13.42% |
| Telemark Asset Management, Llc | $2,675.00 | 5.18% | 414,124 | <1 | 0% | 2025-09-30 |
| Birchview Capital, Lp | $1,853.00 | 3.59% | 286,804 | -2 | <0.01% | 2025-09-30 |
| Vanguard Group Inc | $1,175.00 | 2.27% | 181,904 | -7,764 | -4.09% | 2025-09-30 |
| Perceptive Advisors Llc | $702.00 | 1.36% | 108,694 | 0 | 0% | 2025-09-30 |
| Monashee Investment Management Llc | $646.00 | 1.25% | 99,996 | -4 | <0.01% | 2025-09-30 |
| Perkins Capital Management Inc | $340.00 | 0.66% | 52,633 | -353 | -0.67% | 2025-09-30 |
| Silverarc Capital Management, Llc | $320.00 | 0.62% | 49,607 | -3,911 | -7.31% | 2025-09-30 |
| Gsa Capital Partners Llp | $312.00 | 0.6% | 48,342 | +1,772 | +3.81% | 2025-09-30 |
| Balyasny Asset Management L.P. | $278.00 | 0.54% | 43,024 | +48 | +0.11% | 2025-09-30 |
| Geode Capital Management, Llc | $260.00 | 0.5% | 40,218 | +2,674 | +7.12% | 2025-09-30 |